United States · How much has Noveome Biotherapeutics raised?
Noveome Biotherapeutics has raised $15M across 1 round since 2019.
United States · Series D startup
Who invested in Noveome Biotherapeutics
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Noveome Biotherapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$15Mraised across 1 round since 2019, from 1 source
- Latest round
- Series D, $15MApr 2019
- Investors
- 0
The rounds
- Apr 2019Series D$15M
No investor was named in the report.
Reported by FinSMEsSEC filing: $15M sold, first sale Jan 2018
Founders and team
From Noveome Biotherapeutics's own website: 4 on the team.
- Patrick T. WelchCEO/Board Member
- Craig NemiroffBoard Member
- Mayo ClinicChair of Cardiothoracic Surgery
- Michael KaufmanBoard Member
Quick answers about Noveome Biotherapeutics
When did Noveome Biotherapeutics last raise?
Noveome Biotherapeutics's most recent round was a Series D of $15M in Apr 2019.
What was Noveome Biotherapeutics's biggest round?
Its most recent round, $15M in Apr 2019, is also its largest on record.
What stage is Noveome Biotherapeutics at?
Noveome Biotherapeutics's latest named round is a Series D, in Apr 2019.
Where is Noveome Biotherapeutics based?
Noveome Biotherapeutics is based in the United States.
Companies like Noveome Biotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.